Literature DB >> 33752604

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions.

Andrea L Schaffer1, Timothy A Dobbins2, Sallie-Anne Pearson3,4.   

Abstract

BACKGROUND: Interrupted time series analysis is increasingly used to evaluate the impact of large-scale health interventions. While segmented regression is a common approach, it is not always adequate, especially in the presence of seasonality and autocorrelation. An Autoregressive Integrated Moving Average (ARIMA) model is an alternative method that can accommodate these issues.
METHODS: We describe the underlying theory behind ARIMA models and how they can be used to evaluate population-level interventions, such as the introduction of health policies. We discuss how to select the shape of the impact, the model selection process, transfer functions, checking model fit, and interpretation of findings. We also provide R and SAS code to replicate our results.
RESULTS: We illustrate ARIMA modelling using the example of a policy intervention to reduce inappropriate prescribing. In January 2014, the Australian government eliminated prescription refills for the 25 mg tablet strength of quetiapine, an antipsychotic, to deter its prescribing for non-approved indications. We examine the impact of this policy intervention on dispensing of quetiapine using dispensing claims data.
CONCLUSIONS: ARIMA modelling is a useful tool to evaluate the impact of large-scale interventions when other approaches are not suitable, as it can account for underlying trends, autocorrelation and seasonality and allows for flexible modelling of different types of impacts.

Entities:  

Keywords:  Autoregressive integrated moving average models; Interrupted time series analysis; Intervention analysis; Policy evaluation

Mesh:

Substances:

Year:  2021        PMID: 33752604      PMCID: PMC7986567          DOI: 10.1186/s12874-021-01235-8

Source DB:  PubMed          Journal:  BMC Med Res Methodol        ISSN: 1471-2288            Impact factor:   4.615


  25 in total

1.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

2.  A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation.

Authors:  Atle Fretheim; Fang Zhang; Dennis Ross-Degnan; Andrew D Oxman; Helen Cheyne; Robbie Foy; Steve Goodacre; Jeph Herrin; Ngaire Kerse; R James McKinlay; Adam Wright; Stephen B Soumerai
Journal:  J Clin Epidemiol       Date:  2014-12-11       Impact factor: 6.437

3.  The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?

Authors:  Andrea L Schaffer; Nicholas A Buckley; Timothy A Dobbins; Emily Banks; Sallie-Anne Pearson
Journal:  Med J Aust       Date:  2015-06-15       Impact factor: 7.738

4.  Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use.

Authors:  Andrea L Schaffer; Nicholas A Buckley; Rose Cairns; Sallie-Anne Pearson
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

5.  The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.

Authors:  Jonathan Brett; Andrea Schaffer; Timothy Dobbins; Nicholas A Buckley; Sallie-Anne Pearson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-28       Impact factor: 2.890

6.  Seasonality and temporal correlation between community antibiotic use and resistance in the United States.

Authors:  Lova Sun; Eili Y Klein; Ramanan Laxminarayan
Journal:  Clin Infect Dis       Date:  2012-07-01       Impact factor: 9.079

7.  The use of controls in interrupted time series studies of public health interventions.

Authors:  James Lopez Bernal; Steven Cummins; Antonio Gasparrini
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

8.  A methodological framework for model selection in interrupted time series studies.

Authors:  J Lopez Bernal; S Soumerai; A Gasparrini
Journal:  J Clin Epidemiol       Date:  2018-06-06       Impact factor: 6.437

9.  How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed.

Authors:  Stephen B Soumerai; Douglas Starr; Sumit R Majumdar
Journal:  Prev Chronic Dis       Date:  2015-06-25       Impact factor: 2.830

10.  The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: a time series analysis.

Authors:  Andrea Schaffer; David Muscatello; Michelle Cretikos; Robin Gilmour; Sean Tobin; James Ward
Journal:  BMC Public Health       Date:  2012-10-12       Impact factor: 3.295

View more
  30 in total

1.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

2.  Distributed lag interrupted time series model for unclear intervention timing: effect of a statement of emergency during COVID-19 pandemic.

Authors:  Daisuke Yoneoka; Takayuki Kawashima; Yuta Tanoue; Shuhei Nomura; Akifumi Eguchi
Journal:  BMC Med Res Methodol       Date:  2022-07-25       Impact factor: 4.612

3.  Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.

Authors:  Andrea L Schaffer; David Henry; Helga Zoega; Julian H Elliott; Sallie-Anne Pearson
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

4.  The early impact of the COVID-19 pandemic on patients with severe mental illness: An interrupted time-series study in South-East England.

Authors:  Ed Penington; Belinda Lennox; Galit Geulayov; Keith Hawton; Apostolos Tsiachristas
Journal:  Eur Psychiatry       Date:  2022-05-18       Impact factor: 7.156

5.  Treatment seeking for alcohol-related issues during the COVID-19 pandemic: An analysis of an addiction-specialized psychiatric treatment facility.

Authors:  Mitchell J Andersson; Anders Håkansson
Journal:  Heliyon       Date:  2022-07-14

6.  Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic.

Authors:  Roland Kocijan; Theresa Stockinger; Judith Haschka; Berthold Reichardt; Heinrich Resch; Jochen Zwerina; Martina Behanova
Journal:  Bone       Date:  2022-06-29       Impact factor: 4.626

7.  The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis.

Authors:  Katie J Suda; Katherine Callaway Kim; Inmaculada Hernandez; Walid F Gellad; Scott Rothenberger; Allen Campbell; Lisa Malliart; Mina Tadrous
Journal:  J Am Pharm Assoc (2003)       Date:  2021-12-24

8.  Incidence of childhood cancer in Canada during the COVID-19 pandemic.

Authors:  Marie-Claude Pelland-Marcotte; Lin Xie; Randy Barber; Sulaf Elkhalifa; Mylene Frechette; Jaskiran Kaur; Jay Onysko; Eric Bouffet; Conrad V Fernandez; David Mitchell; Meera Rayar; Alicia Randall; David Stammers; Valérie Larouche; Alexandra Airhart; Miranda Fidler-Benaoudia; Sarah Cohen-Gogo; Lillian Sung; Paul Gibson
Journal:  CMAJ       Date:  2021-11-29       Impact factor: 8.262

9.  Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study.

Authors:  Monica Tang; Benjamin Daniels; Maria Aslam; Andrea Schaffer; Sallie-Anne Pearson
Journal:  Lancet Reg Health West Pac       Date:  2021-08-03

Review 10.  Current Practices in Missing Data Handling for Interrupted Time Series Studies Performed on Individual-Level Data: A Scoping Review in Health Research.

Authors:  Juan Carlos Bazo-Alvarez; Tim P Morris; James R Carpenter; Irene Petersen
Journal:  Clin Epidemiol       Date:  2021-07-23       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.